ASPIRE BIOPHARMA HOLDINGS, INC. (ASBPW) Operating cash flow 2022–2025
ASPIRE BIOPHARMA HOLDINGS, INC. (ASBPW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.9MFY2025 · since FY2022: -$1.4M → -$4.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.9M | -1756.6% |
| FY2024 | -$265,186 | +59.4% |
| FY2023 | -$653,107 | +53.6% |
| FY2022 | -$1.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice